-
New therapy or promising treatment for macular degenerative eye disease
Time of Update: 2020-06-03
Business, April 3 (Upi) -- A cytokine leukocyte interleukin-18 with immunomodulating is expected to be used to treat age-related macular degeneration, a "major breakthrough" in the treatment of com
-
Major new drug creations keep a close eye on clinical needs
Time of Update: 2020-06-03
Business Agency March 25 - Major new drug creation technology major special 2015 project declaration work started, focusing on cutting-edge technology, support enterprises to carry out key technolog
-
"Major new drug creation" special to encourage major varieties of research and development and industrialization
Time of Update: 2020-06-03
Business Agency, March 14 Ministry of Health, the Ministry of Health after the 13th issued the "major new drug creation" science and technology major special "12th Five-Year Plan" implementation
-
New method can damage tumor cell 'protection wall'
Time of Update: 2020-06-02
Medicines Network, August 28 (Upi) -- Researchers have found a new way to destroy the "walls of protection" around tumor cells, effectively killing cancer cells, according to a study released by the
-
Scientists are expected to develop new anti-cancer therapies that have no damaging effect on healthy cells
Time of Update: 2020-06-02
Medicines Network, Aug 13 (Xinhua) -- In a study published in the international journal Journal of Bio Chemicalry, scientists from Oregon State University are looking to develop a new type of effect
-
Discussion on innovative medical device clinical trials: feasibility tests
Time of Update: 2020-06-02
Medicine s august 14 As the domestic industry upgrades and transforms the state strongly encourages innovation, which also includes policy support for medical devices The state has promulgated r
-
A total of 44 new class 1 drugs have been certified since the launch of the new drug creation special
Time of Update: 2020-06-02
Medicine network August 2nd, "major new drug creation" national science and technology major special project was launched in 2008, the implementation period is 2008-2020 This relationship between th
-
Antihypertensive drug research and development shows three major trends
Time of Update: 2020-06-02
Medicine Network August 6th, according to poor compliance is currently one of the main problems to be solved in antihypertensive treatment ideal antihypertensive drugs are best able to have the fo
-
Misoprosol tablet consistency evaluation has been accepted China Resources, Xianyu rush to attack
Time of Update: 2020-06-02
Pharmaceutical Network August 15th, August 14th, Sendo Pharmaceuticals issued a notice that the company's misoprostol tablet consistency evaluation has been accepted, is currently under review and a
-
Playing "The Lancet" Domestic medical robot is going to clinical
Time of Update: 2020-06-02
Medicine Network August 8th, "Da Vinci" is not the ancestor of surgical robots "The first robotic-assisted surgery was performed in 1985, when industrial robots were used to stabilize the patient's
-
Awesome! Haisco's first application for new narcotic drug to be marketed accepted
Time of Update: 2020-06-02
Pharmaceutical Network August 2, July 31, Haisco announced that the company and its wholly-owned subsidiaries Sichuan Haisco Pharmaceutical Co., Ltd., Liaoning Haisco Pharmaceutical Co., Ltd on July
-
Scientists develop new treatment for non-alcoholic fatty liver!
Time of Update: 2020-06-02
Medicines Network, August 20, published in the international journal The Lancet Gastroenterology and Hepatology, scientists from the Medical University of Vienna, Austria, explained the synthetic bi
-
The first review! Rundu Pharmaceutical ibuprofen capsules through generic drug consistency evaluation
Time of Update: 2020-06-02
Pharmaceutical Network August 19 - Zhuhai Rundu Pharmaceutical Co., Ltd (referred to as: Rundu shares) recently received the State Drug Administration approved the issue of the chemical drug "ibupro
-
30 countries, 6000 plus doctors new coronapneumonia survey: hydroxychloroquine "most effective", azithromycin ranked second
Time of Update: 2020-05-30
Guide: The survey found that 37 percent of doctors treating patients with new coronary pneumonia consider hydroxychloroquine to be the "most effective" of the 15 drugs An international survey of mor
-
Shimedicine European-Italian first imitation of Afatini listing application accepted
Time of Update: 2020-05-30
Pharmaceutical Network May 28th, May 27th, CDE official website shows that the stone medicine Oyi according to imitation 4 categories of malayacid afatinib tablets submitted to the listing applicatio
-
Chinese scholars find anti-new crown all-human source nanoantibodies could be developed into new drugs
Time of Update: 2020-05-30
Medicine Network On May 28th, reporters learned that Fudan University School of Basic Medicine Professor Tianlei and other researchers found a series of anti-new coronary whole-human source nanoantib
-
Artesunate intravenous injection approved in the U.S.
Time of Update: 2020-05-30
MAY 28 (UPI) -- THE U.S FOOD AND DRUG ADMINISTRATION (FDA) RECENTLY APPROVED AMIVAS INC.'S ARTESUNATE FOR INJECTION, A TREATMENT FOR SEVERE MALARIA IN ADULTS AND CHILDREN The drug was approved throug
-
The temperature and humidity incubator appear slower, humidity fault, how to solve?
Time of Update: 2020-05-29
" Pharmaceutical Network Technical Article " Constant temperature and humidity incubator with precise temperature and humidity control system, for biotechnology testing to provide the required vario
-
3 billion anti-infective injections, Colum Pharmaceuticals successfully entered
Time of Update: 2020-05-29
Pharmaceutical Network May 29th, May 25, the official website of the State Drug Administration showed that The injection of Melosilin sodium subatan sodium of Colum Pharmaceuticals, a subsidiary of C
-
What are the limitations of China's new drug development system exposed in the new crown epidemic?
Time of Update: 2020-05-28
Medicine son, May 27 (Upi) -- At this stage, so much hope is pinned on Redcieway, reflecting the failure, not success, of our new drug development system It is a classic example of why we need a new